4NK9 | Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1 | date | 2013-11-12 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Norman, R.A., Klein, T. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.57 | ||||||||||||
ligand | 2K5, EDO, SO4 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures., Klein T, Tucker J, Holdgate GA, Norman RA, Breeze AL, ACS Med Chem Lett. 2013 Dec 6;5(2):166-71. doi: 10.1021/ml4004205. eCollection, 2014 Feb 13. PMID:24900792 |
Data retrieval |
View 4NK9 in 3D |
Visual 3D analysis of 4NK9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4NK9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |